Browsing: Health

WASHINGTON, November 28, 2025: The U.S. Food and Drug Administration (FDA) has expanded a nationwide recall of imported cookware after new testing confirmed that several products may release hazardous levels of lead into food, posing long-term health risks to consumers.

WASHINGTON, November 24, 2025: Scientists at the Massachusetts Institute of Technology have identified a method that may restore vision in individuals affected by amblyopia, commonly known as “lazy eye,” by temporarily resetting the retina to an early developmental state. The

WASHINGTON, November 8, 2025: The United States Department of State has issued new instructions to consular offices worldwide expanding the list of medical conditions that may lead to visa denials. Under the updated guidance, chronic illnesses including obesity, diabetes, and cardiovascular disease are

Washington, October 31, 2025: The U.S. Food and Drug Administration (FDA) has announced a nationwide recall of more than 580,000 bottles of the blood pressure drug Prazosin Hydrochloride after testing revealed elevated levels of a nitrosamine impurity known to increase

BOISE, Idaho, October 27, 2025: Idaho has enacted a first-of-its-kind state law that bans nearly all vaccine mandates, a move that has drawn national attention and praise from medical freedom advocates while prompting warnings from public health officials. The Idaho

TEXAS, October 23, 2025: Scientists at the Texas A&M University Health Science Center have identified a hidden cellular mechanism that fuels one of the most aggressive forms of kidney cancer affecting children and young adults. The discovery, published in Nature

WASHINGTON, Oct. 19: A new investigation by Consumer Reports has found that several widely sold protein powders and shakes in the United States contain high levels of lead and other heavy metals, raising concerns over product safety and consumer health.

SAN FRANCISCO, October 7, 2025: A new study led by researchers from Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, and Stanford University School of Medicine has identified how a molecule produced

The U.S. Food and Drug Administration (FDA) approved a second generic version of the abortion pill mifepristone on October 2, 2025, just hours before a potential government shutdown that would have paused regulatory functions. The decision allows Evita Solutions to

October 2, 2025, New York: Four decades of dedicated breast cancer awareness campaigns have helped save more than 517,000 lives, marking a significant milestone in the global fight against one of the most common cancers affecting women. According to the